Featured Suppliers:

BioVeris Corporation

Refined by:

Industry: Healthcare & Medicine

Web Sites

Roche - Media News - Roche completes acquisition of Igen

The acquisition of Igen ends a long standing patent dispute and gives Roche broad access to the human in-vitro diagnostics (IVD) immunochemistry sector. Valued at 7.5 billion Swiss francs, immunochemistry is the biggest segment of the in-vitro diagnostics market.

http://www.roche.com/med-cor-2004-02-16

Immunoassay Systems - Used Surplus Equipment

Receive Email Notifications via LabX Alerts! Enter your favorite search terms, favorite LabX category, or favorite LabX seller and be notified daily, weekly, or monthly by email when ads are entered which match your criteria.

http://www.labx.com/v2/newad.cfm?catID=416

Pharmacy Choice - Pharmaceutical News - Roche Completes Acquisition of BioVeris - August 6, 2007

2007 JUL 13 - (NewsRx.com) -- Roche Diagnostics today announces that it has completed its acquisition of BioVeris. Roche signed the merger agreement with BioVeris for approximately $600 million on April 4, 2007.

http://www.pharmacychoice.com/News/article.cfm?Article_ID=61865

Licensing Agreements - BioVeris completes additional vaccine license

',250)" onMouseout="hideddrivetip()">Haemophilus influenzae type b (Hib) components in new vaccine A substance or group of substances meant to cause the immune system to respond to a tumor or to microorganisms, such as bacteria or viruses.

http://www.newsrx.com/newsletters/Vaccine-Weekly/2007-02-28/420228200710VW.html